Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 341
Filtrar
Más filtros

Intervalo de año de publicación
4.
Thorac Cardiovasc Surg ; 69(1): 10-12, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32114692

RESUMEN

Six billion people worldwide lack access to safe, timely, and affordable cardiac surgical care when needed, despite cardiovascular diseases remaining the world's leading cause of mortality. The large surgical backlog of rheumatic heart disease, stable and high incidence of congenital heart disease, and growing burden of ischemic heart disease around the world calls for urgent scaling of cardiovascular services beyond mere prevention. National Surgical, Obstetric, and Anesthesia Plans are being developed by countries as holistic health systems interventions to increase access to surgical care, but to date, limited to no attention has been given to the inclusion of cardiovascular care.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Cardiología/organización & administración , Prestación Integrada de Atención de Salud/organización & administración , Salud Global , Accesibilidad a los Servicios de Salud/organización & administración , Cardiopatías/cirugía , Programas Nacionales de Salud/organización & administración , Anestesiología/organización & administración , Procedimientos Quirúrgicos Cardíacos/legislación & jurisprudencia , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Regulación Gubernamental , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Necesidades y Demandas de Servicios de Salud/organización & administración , Cardiopatías/diagnóstico , Cardiopatías/mortalidad , Humanos , Evaluación de Necesidades/organización & administración , Obstetricia/organización & administración , Formulación de Políticas
5.
Salud Colect ; 16: e2210, 2020 04 05.
Artículo en Inglés, Español | MEDLINE | ID: mdl-32574450

RESUMEN

This study discusses actors and institution movements leading to the disclosure in 2014 of Resolution 199 by the Brazilian Ministry of Health, which establishes the National Policy for the Comprehensive Care of Persons with Rare Diseases. Taking as sources the mainstream newspapers, drafts law, and secondary literature on the subject, we begin our analysis in the early 1990s when the first patient associations were created in Brazil - mainly for claiming more funds for research on genetic diseases - and arrive at the late 2010s when negotiations for a national policy are taking place in the National Congress. Resolution 199 is part of an ongoing process and the path towards its disclosure and the complications that followed have given us elements to discuss contemporary aspects of the Brazilian public health. Based on the references of the history of the present time and the social studies of science, we argue that two aspects have been fundamental to creating a national policy: framing different illnesses within the terminology "rare diseases" and the construction of a public perception about the right of health which is guaranteed by the 1988 Brazilian Constitution.


En este trabajo se analizan los movimientos de actores e instituciones que llevaron a la promulgación, en 2014, de la Resolución 199 del Ministerio de Salud de Brasil, que establece la Política Nacional de Atención Integral a las Personas con Enfermedades Raras. Tomando como fuentes los principales periódicos, proyectos de ley y bibliografía secundaria sobre el tema, comenzamos nuestro análisis a principios de la década de 1990 con la creación de las primeras asociaciones de pacientes en Brasil, para reclamar fundamentalmente más fondos para la investigación de enfermedades genéticas, y llegamos a fines de la década de 2010 con las negociaciones para una política nacional. La Resolución 199 es parte de un proceso en curso, en el que el camino hacia la promulgación y las complicaciones posteriores nos dan elementos para discutir aspectos actuales de la salud pública brasileña. Sobre la base de la historia del tiempo presente y los estudios sociales de la ciencia, argumentamos que hay dos aspectos que han sido fundamentales para crear una política nacional: enmarcar diferentes enfermedades en la terminología "enfermedades raras" y la construcción de una percepción pública sobre el derecho a la salud, que se garantiza en la Constitución brasileña de 1988.


Asunto(s)
Enfermedades Genéticas Congénitas , Genética Médica , Política de Salud , Programas Nacionales de Salud , Enfermedades Raras , Brasil , Prestación Integrada de Atención de Salud/historia , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Enfermedades Genéticas Congénitas/historia , Enfermedades Genéticas Congénitas/terapia , Genética Médica/historia , Política de Salud/economía , Política de Salud/historia , Política de Salud/legislación & jurisprudencia , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Programas Nacionales de Salud/economía , Programas Nacionales de Salud/historia , Programas Nacionales de Salud/legislación & jurisprudencia , Programas Nacionales de Salud/organización & administración , Periódicos como Asunto , Derechos del Paciente , Política , Enfermedades Raras/clasificación , Enfermedades Raras/genética , Enfermedades Raras/historia , Enfermedades Raras/terapia , Grupos de Autoayuda/historia , Grupos de Autoayuda/organización & administración , Terminología como Asunto
6.
J Vasc Surg ; 72(4): 1166-1172, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32454232

RESUMEN

Singapore was one of the first countries to be affected by COVID-19, with the index patient diagnosed on January 23, 2020. For 2 weeks in February, we had the highest number of COVID-19 cases behind China. In this article, we summarize the key national and institutional policies that were implemented in response to COVID-19. We also describe in detail, with relevant data, how our vascular surgery practice has changed because of these policies and COVID-19. We show that with a segregated team model, the vascular surgery unit can still function while reducing risk of cross-contamination. We explain the various strategies adopted to reduce outpatient and inpatient volume. We provide a detailed breakdown of the type of vascular surgical cases that were performed during the COVID-19 pandemic and compare it with preceding months. We discuss our operating room and personal protective equipment protocols in managing a COVID-19 patient and share how we continue surgical training amid the pandemic. We also discuss the challenges we might face in the future as COVID-19 regresses.


Asunto(s)
Infecciones por Coronavirus/terapia , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Política de Salud/legislación & jurisprudencia , Necesidades y Demandas de Servicios de Salud/legislación & jurisprudencia , Neumonía Viral/terapia , Formulación de Políticas , Centros de Atención Terciaria/legislación & jurisprudencia , Procedimientos Quirúrgicos Vasculares/legislación & jurisprudencia , Atención Ambulatoria/legislación & jurisprudencia , Atención Ambulatoria/organización & administración , Betacoronavirus/patogenicidad , COVID-19 , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/virología , Prestación Integrada de Atención de Salud/organización & administración , Necesidades y Demandas de Servicios de Salud/organización & administración , Departamentos de Hospitales/legislación & jurisprudencia , Departamentos de Hospitales/organización & administración , Interacciones Huésped-Patógeno , Humanos , Control de Infecciones/legislación & jurisprudencia , Control de Infecciones/organización & administración , Salud Laboral/legislación & jurisprudencia , Pandemias , Grupo de Atención al Paciente/legislación & jurisprudencia , Grupo de Atención al Paciente/organización & administración , Seguridad del Paciente/legislación & jurisprudencia , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Neumonía Viral/virología , Evaluación de Programas y Proyectos de Salud , SARS-CoV-2 , Singapur/epidemiología , Centros de Atención Terciaria/organización & administración , Carga de Trabajo/legislación & jurisprudencia
7.
Neurotoxicology ; 81: 238-245, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-33741109

RESUMEN

Services aimed at improving the health of infants, children and mothers have developed over the years since the initiation of the Seychelles Child Development Study. This paper describes the policies, procedures and facilities and how they have impacted on service provision. The utilisation of antenatal, perinatal and child health services, both in the hospital and community settings, are described. The successes and challenges are illustrated by describing fertility, abortion, teenage pregnancy and infant mortality. This overview of maternal and child services provides a perspective on an important aspect of health care development and the context in which the SCDS is conducted.


Asunto(s)
Servicios de Salud del Niño , Salud Infantil , Prestación Integrada de Atención de Salud , Política de Salud , Salud del Lactante , Servicios de Salud Materna , Salud Materna , Aborto Inducido , Aborto Espontáneo/epidemiología , Adolescente , Adulto , Niño , Desarrollo Infantil , Salud Infantil/legislación & jurisprudencia , Salud Infantil/tendencias , Servicios de Salud del Niño/legislación & jurisprudencia , Servicios de Salud del Niño/tendencias , Mortalidad del Niño , Preescolar , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Prestación Integrada de Atención de Salud/tendencias , Femenino , Fertilidad , Regulación Gubernamental , Política de Salud/legislación & jurisprudencia , Política de Salud/tendencias , Humanos , Lactante , Salud del Lactante/legislación & jurisprudencia , Salud del Lactante/tendencias , Mortalidad Infantil , Recién Nacido , Masculino , Salud Materna/legislación & jurisprudencia , Salud Materna/tendencias , Servicios de Salud Materna/legislación & jurisprudencia , Servicios de Salud Materna/tendencias , Mortalidad Materna , Formulación de Políticas , Embarazo , Embarazo en Adolescencia , Seychelles , Factores de Tiempo , Adulto Joven
11.
Lancet Oncol ; 20(11): e645-e652, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31674323

RESUMEN

When developed and implemented effectively, national cancer control plans (NCCPs) improve cancer outcomes at the population level. However, many countries do not have a high-quality, operational NCCP, contributing to disparate cancer outcomes globally. Until now, a standard reference of NCCP core elements has not been available to guide development and evaluation across diverse countries and contexts. In this Policy Review, we describe the methods, process, and outcome of an initiative to develop an itemised and evidence-based comprehensive checklist of core elements for NCCP formulation. The final list provides a ready-to-use guide to support NCCP development and to facilitate internal and external critical appraisal of existing NCCPs for countries of all income levels and settings. Governments, policy makers, and stakeholders can utilise this checklist, while considering their own unique contexts and priorities, from the drafting through to the implementation of NCCPs.


Asunto(s)
Prestación Integrada de Atención de Salud/organización & administración , Salud Global , Planificación en Salud/organización & administración , Política de Salud , Oncología Médica/organización & administración , Neoplasias/terapia , Lista de Verificación , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Salud Global/legislación & jurisprudencia , Planificación en Salud/legislación & jurisprudencia , Política de Salud/legislación & jurisprudencia , Humanos , Oncología Médica/legislación & jurisprudencia , Modelos Organizacionales , Neoplasias/diagnóstico , Neoplasias/mortalidad , Formulación de Políticas
12.
Circ J ; 83(9): 1819-1821, 2019 08 23.
Artículo en Inglés | MEDLINE | ID: mdl-31391350

RESUMEN

Heart failure pandemic is rapidly approaching in Japan, requiring nationwide actions. In particular, the Japanese Circulation Society and related societies launched the Stroke and Cardiovascular Disease Control Act, which was passed by the National Diet, as the first ever legislative policy measure against stroke and cardiovascular disease. In association with this, actions against heart failure pandemic from the scientific field are also important. Because heart failure pandemic is a critical problem not only in Japan but also in many developed countries, we believe the nationwide approach, as summarized here, will greatly contribute to the development of cardiovascular medicine, particularly the management and treatment of heart failure worldwide.


Asunto(s)
Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Política de Salud , Insuficiencia Cardíaca/terapia , Pandemias , Formulación de Políticas , Sociedades Médicas/legislación & jurisprudencia , Sociedades Científicas/legislación & jurisprudencia , Investigación Biomédica/legislación & jurisprudencia , Necesidades y Demandas de Servicios de Salud/legislación & jurisprudencia , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/epidemiología , Humanos , Japón/epidemiología , Evaluación de Necesidades/legislación & jurisprudencia , Servicios Preventivos de Salud/legislación & jurisprudencia , Factores de Riesgo
13.
Semin Reprod Med ; 37(1): 12-16, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-31185513

RESUMEN

Infertility prevalence and care needs among male and female Veterans are understudied topics. The Veterans Health Administration (VHA) medical benefits package covers full infertility evaluation and many infertility treatments for Veterans but not, by law, for their spouses. In vitro fertilization (IVF) is also specifically excluded from this medical benefits package by regulation. Congress passed a law in 2016 that allowed VHA to provide IVF to Veterans and their legal spouses, and broader infertility benefits to the legal spouse, if the Veteran has a service-connected condition associated with his or her infertility, with some limitations. As the Veteran population becomes increasingly female, research efforts in reproductive health, including infertility, are expanding and evolving. This includes a nationwide study currently underway examining infertility among male and female Veterans and associations with military-related trauma, such as injury, posttraumatic stress disorder, military sexual trauma, and toxin exposure. In this review, we describe the state of the science and policy on infertility care in the VHA along with challenges and opportunities that exist within the VHA system.


Asunto(s)
Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Infertilidad/terapia , Salud Reproductiva/legislación & jurisprudencia , Medicina Reproductiva/legislación & jurisprudencia , Técnicas Reproductivas Asistidas/legislación & jurisprudencia , United States Department of Veterans Affairs/legislación & jurisprudencia , Servicios de Salud para Veteranos/legislación & jurisprudencia , Salud de los Veteranos/legislación & jurisprudencia , Femenino , Fertilidad , Regulación Gubernamental , Humanos , Infertilidad/diagnóstico , Infertilidad/fisiopatología , Masculino , Formulación de Políticas , Estados Unidos
15.
J Gen Intern Med ; 34(Suppl 1): 18-23, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-31098968

RESUMEN

In response to widespread concerns regarding Veterans' access to VA care, Congress enacted the Veterans Access, Choice and Accountability Act of 2014, which required VA to establish the Veterans Choice Program (VCP). Since the inception of VCP, more than two million Veterans have received care from community providers, representing approximately 25% of Veterans enrolled in VA care. However, expanded access to non-VA care has created challenges in care coordination between VA and community health systems. In March 2018, the VA Health Services Research & Development Service hosted a VA State of the Art conference (SOTA) focused on care coordination. The SOTA convened VA researchers, program directors, clinicians, and policy makers to identify knowledge gaps regarding care coordination within the VA and between VA and community systems of care. This article provides a summary and synthesis of relevant literature and provides recommendations generated from the SOTA about how to evaluate cross-system care coordination. Care coordination is typically evaluated using health outcomes including hospital readmissions and death; however, in cross-system evaluations of care coordination, measures such as access, cost, Veteran/patient and provider satisfaction (including with cross-system communication), comparable quality metrics, context (urban vs. rural), and patient complexity (medical and mental health conditions) need to be included to fully evaluate care coordination effectiveness. Future research should examine the role of multiple individuals coordinating VA and non-VA care, and how these coordinators work together to optimize coordination.


Asunto(s)
Continuidad de la Atención al Paciente/organización & administración , Prestación Integrada de Atención de Salud/organización & administración , Accesibilidad a los Servicios de Salud/organización & administración , Continuidad de la Atención al Paciente/economía , Continuidad de la Atención al Paciente/legislación & jurisprudencia , Prestación Integrada de Atención de Salud/economía , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Accesibilidad a los Servicios de Salud/economía , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Humanos , Calidad de la Atención de Salud/economía , Calidad de la Atención de Salud/organización & administración , Estados Unidos , United States Department of Veterans Affairs/legislación & jurisprudencia , United States Department of Veterans Affairs/organización & administración , Salud de los Veteranos/legislación & jurisprudencia
16.
Afr J Prim Health Care Fam Med ; 11(1): e1-e8, 2019 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-31038335

RESUMEN

BACKGROUND:  Mental health care at primary health care (PHC) still remains a challenge despite the Policy on Integration of Mental Health Care into PHC which was developed in 1997 at the time when the White Paper for the Transformation of the Health System in South Africa was published. The White Paper made provision for a new health care system based on the principles of the PHC approach to care. This was followed by the promulgation of the Mental Health Care Act No. 17 of 2002 which is based on the principle that mental health care should be integrated into PHC; however, there have been challenges with regard to the implementation of this policy. AIM:  This study aimed to analyse the implementation of Policy on Integration of Mental Health Care into PHC with the ultimate aim of developing a practice framework for PHC nurses to enhance such implementation in KwaZulu-Natal (KZN). SETTING:  The study took place in selected health districts in KZN, namely, Ugu, eThekwini, iLembe and uMgungundlovu. METHODS:  A qualitative approach using grounded theory design was used to develop a practice framework to enhance the implementation of Policy on Integration of Mental Health Care into PHC. A theoretical sampling method was used to select the sample from PHC managers, operational managers and professional nurses for the collection of data. The sample consisted of 42 participants. Data were collected by means of one-on-one interviews and focus group interviews. Strauss and Corbin's approach of data analysis was used for analysing data. The paradigm model was used as a guide to develop a practice framework to enhance the implementation of the Policy on Integration of Mental Health Care into PHC in KZN. RESULTS:  This study found that integration of mental health care into PHC is understood as a provision of comprehensive care to mental health care users using either a supermarket approach or a one-stop-shop approach at PHC clinics. Strategies that are used at PHC clinics in KZN ensure that the integration of mental health care into PHC is implemented, includes the screening of all patients that come to the PHC clinic for mental illness, fast tracking of mental health care users once they have been assessed, and found to be mentally ill and management of all mental health care users as patients with chronic diseases. CONCLUSION:  The practice framework developed identifies comprehensive mental health care being offered to mental health care users using either a supermarket approach or a one-stop-shop approach, depending on the availability of staff with a qualification in psychiatric nursing science.


Asunto(s)
Prestación Integrada de Atención de Salud/métodos , Implementación de Plan de Salud/métodos , Política de Salud/legislación & jurisprudencia , Servicios de Salud Mental/legislación & jurisprudencia , Atención Primaria de Salud/métodos , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Grupos Focales , Reforma de la Atención de Salud/legislación & jurisprudencia , Humanos , Tamizaje Masivo/métodos , Trastornos Mentales/diagnóstico , Trastornos Mentales/terapia , Atención Primaria de Salud/legislación & jurisprudencia , Investigación Cualitativa , Sudáfrica
19.
J Subst Abuse Treat ; 97: 41-46, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30577898

RESUMEN

BACKGROUND: Federal regulations (42 CFR Part 2) provide special privacy protections for persons seeking treatment for substance use disorders. Primary care providers, hospitals, and health care organizations have struggled to balance best practices for medical care with adherence to 42 CFR Part 2, but little formal research has examined this issue. The aim of this study was to explore institutional variability in the interpretation and implementation of 42 CFR Part 2 regulations related to health systems data privacy practices, policies, and information technology architecture. METHODS: This was a cross-sectional qualitative study using purposive sampling to conduct interviews with privacy/legal officers (n = 17) and information technology specialists (n = 10) from 15 integrated healthcare organizations affiliated with three research nodes of the National Institute on Drug Abuse (NIDA) National Drug Abuse Treatment Clinical Trials Network (CTN). Trained staff completed a short survey and digitally recorded semi-structured qualitative interview with each participant. Interviews were transcribed and coded within Atlas.ti. Framework analysis was used to identify and organize key themes across selected codes. RESULTS: Participants voiced concern over balancing patient safety with 42 CFR Part 2 privacy protections. Although similar standards of protection regarding release of information outside of the health system was described, numerous workarounds were used to manage intra-institutional communication and care coordination. To align 42 CFR Part 2 restrictions with electronic health records, health systems used sensitive note designation, "break the glass" technology, limited role-based access for providers, and ad hoc solutions (e.g., provider messaging). CONCLUSIONS: In contemporary integrated care systems, substance-related EHR records (e.g., patient visit history, medication logs) are often accessible internally without specific consent for sharing despite the intent of 42 CFR Part 2. Recent amendments to 42 CFR Part 2 have not addressed information sharing needs within integrated care settings.


Asunto(s)
Prestación Integrada de Atención de Salud , Registros Electrónicos de Salud , Seguridad del Paciente , Privacidad , Trastornos Relacionados con Sustancias/terapia , Adulto , Estudios Transversales , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Prestación Integrada de Atención de Salud/normas , Registros Electrónicos de Salud/legislación & jurisprudencia , Registros Electrónicos de Salud/normas , Humanos , Seguridad del Paciente/legislación & jurisprudencia , Seguridad del Paciente/normas , Privacidad/legislación & jurisprudencia , Investigación Cualitativa
20.
Ethn Dis ; 29(Suppl 3): 623-628, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31889767

RESUMEN

There is growing recognition that the genomic and precision medicine revolution in health care can deepen health disparities. This has produced urgent calls to prioritize inclusion of historically underrepresented populations in research and to make genomic databases more inclusive. Answering the call to address health care disparities in the delivery of genomic and precision medicine requires a consideration of important, yet understudied, legal issues that have blocked progress. This article introduces a special issue of Ethnicity & Disease which contains a series of articles that grew out of a public conference to investigate these legal issues and propose solutions. This 2018 conference at Meharry Medical College was part of an NIH-funded project on "LawSeqSM" to evaluate and improve the law of genomics in order to support appropriate integration of genomics into clinical care. This conference was composed of presentations and interactive sessions designed to specify the top legal barriers to health equity in precision medicine and stimulate potential solutions. This article synthesizes the results of those discussions. Multiple legal barriers limit broad inclusion in genomic research and the development of precision medicine to advance health equity. Problems include inadequate privacy and anti-discrimination protections for research participants, lack of health coverage and funding for follow-up care, failure to use law to ensure access to genomic medicine, and practices by research sponsors that tolerate and entrench disparities. Analysis of the legal barriers to health equity in precision medicine is essential for progress. Progressive use of law is vital to avoid worsening of health care disparities.


Asunto(s)
Prestación Integrada de Atención de Salud , Genómica/ética , Equidad en Salud , Disparidades en Atención de Salud/etnología , Medicina de Precisión , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Prestación Integrada de Atención de Salud/organización & administración , Etnicidad , Equidad en Salud/ética , Equidad en Salud/legislación & jurisprudencia , Equidad en Salud/organización & administración , Disparidades en Atención de Salud/ética , Humanos , Medicina de Precisión/métodos , Medicina de Precisión/normas , Medicina de Precisión/tendencias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA